Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Stahl

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Human Psychopharmacology|September 21, 2004
Understanding pain in depressionStephen Stahl, Mike Briley
Acta Psychiatrica Scandinavica|September 9, 2004
A successful antipsychotic combination trial. Quo Vadis?Stephen Stahl, Oliver Freudenreich, Donald Goff
CNS Spectrums|December 3, 2025
Ritual to relief: ethical frontiers in repurposing psychoactive substancesEmma O'Leary, Seetal Dodd, Stephen Stahl
Journal of Psychopharmacology (Oxford, England)|March 29, 2023
Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actionsTakesha Cooper, Michael David Seigler, Stephen Stahl
Expert Opinion on Emerging Drugs|August 30, 2022
Emerging drugs for the treatment of major depressive disorderJennifer Hong, Darian Vernon, Jelena Kunovac, et al.
Current Medicinal Chemistry|January 7, 2022
Polypharmacy- Purpose, Benefits and LimitationsDouglas Grover, Michelle Tom, Gerald Maguire, et al.
Nutritional Neuroscience|November 1, 2019
Mental energy: plausible neurological mechanisms and emerging research on the effects of natural dietary compoundsPatrick J O'Connor, David O Kennedy, Stephen Stahl
The International Journal of Neuropsychopharmacology|May 10, 2001
The International Journal of NeuropsychopharmacologyBernard Lerer, Alan Frazer, Stephen Stahl, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2016
Inverse agonists - What do they mean for psychiatry?David Nutt, Stephen Stahl, Pierre Blier, et al.
The Primary Care Companion for CNS Disorders|September 12, 2025
Toward Precision Psychiatry: Innovations and Prospects in Treating DepressionDaphna Laifenfeld, Claudia Albeldas, Talia Cohen Solal, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Human Psychopharmacology|September 21, 2004
Understanding pain in depressionStephen Stahl, Mike Briley
Acta Psychiatrica Scandinavica|September 9, 2004
A successful antipsychotic combination trial. Quo Vadis?Stephen Stahl, Oliver Freudenreich, Donald Goff
CNS Spectrums|December 3, 2025
Ritual to relief: ethical frontiers in repurposing psychoactive substancesEmma O'Leary, Seetal Dodd, Stephen Stahl
Journal of Psychopharmacology (Oxford, England)|March 29, 2023
Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actionsTakesha Cooper, Michael David Seigler, Stephen Stahl
Expert Opinion on Emerging Drugs|August 30, 2022
Emerging drugs for the treatment of major depressive disorderJennifer Hong, Darian Vernon, Jelena Kunovac, et al.
Current Medicinal Chemistry|January 7, 2022
Polypharmacy- Purpose, Benefits and LimitationsDouglas Grover, Michelle Tom, Gerald Maguire, et al.
Nutritional Neuroscience|November 1, 2019
Mental energy: plausible neurological mechanisms and emerging research on the effects of natural dietary compoundsPatrick J O'Connor, David O Kennedy, Stephen Stahl
The International Journal of Neuropsychopharmacology|May 10, 2001
The International Journal of NeuropsychopharmacologyBernard Lerer, Alan Frazer, Stephen Stahl, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2016
Inverse agonists - What do they mean for psychiatry?David Nutt, Stephen Stahl, Pierre Blier, et al.
The Primary Care Companion for CNS Disorders|September 12, 2025
Toward Precision Psychiatry: Innovations and Prospects in Treating DepressionDaphna Laifenfeld, Claudia Albeldas, Talia Cohen Solal, et al.
Pageof 3